AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 536

First Page		Document Content
Date: 2013-09-18 08:45:09 Growth factors Hematology Cytokines HIV/AIDS Granulocyte colony-stimulating factor Filgrastim Pegfilgrastim Neutropenia Chemotherapy Biology Medicine Amgen		AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 536 Add to Reading List Source URL: www.aidsinfonet.org Download Document from Source Website File Size: 89,83 KB Share Document on Facebook

	BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi DocID: 1rrNB - View Document
	Press Release Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency BENGALURU, India and HERTFORDSHIRE, England/PITTSBURGH, USA, July 21, 20 DocID: 1q6vz - View Document
	“You Don’t Know What You’re Missing” Evaluating Competitor Clinical Trials with the BizInt Smart Charts Product Family November 2013 DocID: 1mfkn - View Document
	[ Industry Watch ] INDIA Intas Plans Filgrastim launch in North America, Europe DocID: 1kixC - View Document
	SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid DocID: 1fBTU - View Document